Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Recurrence Score® Result Impacts Treatment Decisions in Hormone Receptor-Positive, HER2-Negative Patients with Early Breast Cancer in a Real-World Setting-Results of the IRMA Trial.
Dannehl D, Engler T, Volmer LL, Staebler A, Fischer AK, Weiss M, Hahn M, Walter CB, Grischke EM, Fend F, Taran FA, Brucker SY, Hartkopf AD. Dannehl D, et al. Among authors: volmer ll. Cancers (Basel). 2022 Oct 31;14(21):5365. doi: 10.3390/cancers14215365. Cancers (Basel). 2022. PMID: 36358784 Free PMC article.
Which Patients Do We Need to Test for BRCA1/2 Mutation? Feasibility of Adjuvant Olaparib Treatment in Early Breast Cancer-Real-World Data from Two Large German Breast Centers.
Dannehl D, Engler T, Volmer LL, Tegeler CM, Fusshoeller J, Gabrysch E, Eissler K, Seller A, Grischke EM, Hahn M, Gruber I, Schochter F, Pfister K, Veselinovic K, Leinert E, Rack B, Fink V, Janni W, Brucker SY, Hartkopf AD, Schäffler H. Dannehl D, et al. Among authors: volmer ll. Cancers (Basel). 2023 Jul 28;15(15):3847. doi: 10.3390/cancers15153847. Cancers (Basel). 2023. PMID: 37568663 Free PMC article.
Comparison of Biosimilar Trastuzumab ABP 980 with Reference Trastuzumab in Neoadjuvant Therapy for HER2-positive Breast Cancer - an Analysis of a Large University Breast Cancer Centre.
Matovina S, Engler T, Volmer LL, Müller H, Grischke EM, Staebler A, Hahn M, Brucker SY, Hartkopf AD. Matovina S, et al. Among authors: volmer ll. Geburtshilfe Frauenheilkd. 2022 Dec 2;83(6):694-701. doi: 10.1055/a-1963-7511. eCollection 2023 Jun. Geburtshilfe Frauenheilkd. 2022. PMID: 37614685 Free PMC article.
Current landscape of hospital information systems in gynecology and obstetrics in Germany: a survey of the commission Digital Medicine of the German Society for Gynecology and Obstetrics.
Pfob A, Griewing S, Seitz K, Hillen C, Becker S, Bayer C, Wagner U, Fasching P, Wallwiener M; Kommission Digitale Medizin, Deutsche Gesellschaft für Gynäkologie und Gebursthilfe (DGGG). Pfob A, et al. Arch Gynecol Obstet. 2023 Dec;308(6):1823-1830. doi: 10.1007/s00404-023-07223-1. Epub 2023 Sep 23. Arch Gynecol Obstet. 2023. PMID: 37740792 Free PMC article.
The Clinical Relevance of the NATALEE Study: Application of the NATALEE Criteria to a Real-World Cohort from Two Large German Breast Cancer Centers.
Schäffler H, Mergel F, Pfister K, Lukac S, Fink A, Veselinovic K, Rack B, Fink V, Leinert E, Dimpfl M, Englisch A, Tegeler CM, Seller A, Grischke EM, Hahn M, Volmer LL, Engler T, Frevert ML, Taran FA, Janni W, Brucker SY, Hartkopf AD, Dannehl D. Schäffler H, et al. Among authors: volmer ll. Int J Mol Sci. 2023 Nov 15;24(22):16366. doi: 10.3390/ijms242216366. Int J Mol Sci. 2023. PMID: 38003555 Free PMC article.
19 results